Paper

Hydroxytyrosol nicotinate, a new multifunctional hypolipidemic and hypoglycemic agent.

Published Mar 1, 2018 · Yundong Xie, Zizhang Chen, Na Li

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro StudyRigorous Journal

Study Snapshot

Hydroxytyrosol nicotinate (HT-N) has hypolipidemic, hypoglycemic, and antioxidant properties, potentially serving as a multifunctional therapeutic strategy for diabetic patients with hyperlipidemia.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Hydroxytyrosol nicotinate, a new multifunctional hypolipidemic and hypoglycemic agent.

References

Citations